Skip to main content
OpenTrials
Completed

NCT Number: NCT03767907

Online Cognitive Behavioural Therapy for Addiction: Efficacy and Cost-Effectiveness in a Pragmatic Clinical Trial

The purpose of this study is to compare the efficacy and cost-effectiveness of a Computer-based Training for Cognitive Behavioural Therapy (CBT4CBT) to treatment as usual in outpatients seeking treatment for substance use disorder.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Campbell Family Mental Health Research Institute, CAMH

Toronto, Ontario, M5S 2S1, Canada

About this study

Fifty-two adult outpatients seeking treatment for substance use disorder from the Centre for Addiction and Mental Health Addictions Program will be randomized to receive either a computer-based training for cognitive behavioural therapy or treatment as usual for eight weeks. Participants will complete interviews, questionnaires, and other assessments (urine toxicology and physiological assessments) at week 0, at week 8, and at 6 month follow-up). Measures will assess alcohol and drug consumption, substance use disorder symptoms and associated features, quality of life, and healthcare costs.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • Fluency in English
  • Understanding and willingness to comply with study requirements
  • Meet diagnostic criteria for current substance use disorder
  • Have used substance in the past 30 days
  • Treatment-seeking for substance misuse

Exclusion criteria

  • Unable to read at sixth grade level
  • Untreated or unstable severe psychiatric or medical disorder
  • Acute suicidal or homicidal ideation

Treatment and study plan

Computer-based Training for Cognitive Behavioural Therapy

Behavioral

Interactive content organized into seven modules, illustrating real-life scenarios associated with common risky situations, which illustrate the application of targeted skills and strategies

Other names: CBT4CBT

Treatment as Usual

Behavioral

Treatment as usual will include standard psychosocial care determined to be appropriate or necessary, on an individual patient basis.

Primary outcomes

  1. Timeline Follow-Back (TLFB)

    Time frame: 30 days

    Frequency (days) of substance use over the past 30 days

Secondary outcomes

  1. Urine Toxicology Screen

    Time frame: 30 days

    Determine substance use in past 30 days

  2. Addiction Severity Index (ASI)

    Time frame: 30 days

    Substance Use Disorder symptom severity

    Subscale scores are calculated for 7 domains (medical, employment/support status, alcohol, drug, legal, family/social and psychological). Subscale scores are summed scores ranging from 0-1 with higher scores indicating greater problem severity.

  3. WHO Quality of Life (WHOQOL-BREF)

    Time frame: 4 weeks

    Quality of Life

    Subscale scores are calculated for 4 domains (physical health, psychological, social relationships and environment) and for "overall" and "general health" quality of life. Subscale scores have a range of 0 to 100 with higher scores indicating greater quality of life.

  4. Program and Client Costs-Substance Abuse Treatment (PACC-SAT)

    Time frame: 7 days

    Healthcare Costs

Sponsors and collaborators

Lead sponsor

Centre for Addiction and Mental Health

Other

Registry information

Important dates

Study start
2018
Primary completion
2020
Study completion
2021
First posted
Dec 7, 2018
Registry last updated
Jul 20, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.